MEDINDIA
English
हिन्दी
Español
français
中文
Email
Abatacept
The risk or severity of infection can be increased when Etanercept is combined with Abatacept.
Abciximab
Etanercept may increase the anticoagulant activities of Abciximab.
Acebutolol
Etanercept may decrease the antihypertensive activities of Acebutolol.
Aceclofenac
The risk or severity of adverse effects can be increased when Etanercept is combined with Aceclofenac.
Acemetacin
The risk or severity of adverse effects can be increased when Etanercept is combined with Acemetacin.
Acenocoumarol
Etanercept may increase the anticoagulant activities of Acenocoumarol.
Acetaminophen
The risk or severity of adverse effects can be increased when Etanercept is combined with Acetaminophen.
Adalimumab
The risk or severity of adverse effects can be increased when Adalimumab is combined with Etanercept.
Adapalene
The risk or severity of adverse effects can be increased when Adapalene is combined with Etanercept.
Alclometasone
The risk or severity of adverse effects can be increased when Etanercept is combined with Alclometasone.
Aldosterone
The risk or severity of adverse effects can be increased when Etanercept is combined with Aldosterone.
Alendronate
The risk or severity of adverse effects can be increased when Etanercept is combined with Alendronic acid.
Alendronic acid
The risk or severity of adverse effects can be increased when Etanercept is combined with Alendronic acid.
Aliskiren
Etanercept may decrease the antihypertensive activities of Aliskiren.
Alminoprofen
The risk or severity of adverse effects can be increased when Alminoprofen is combined with Etanercept.
Alprenolol
Etanercept may decrease the antihypertensive activities of Alprenolol.
Alprostadil
The therapeutic efficacy of Alprostadil can be decreased when used in combination with Etanercept.
Amcinonide
The risk or severity of adverse effects can be increased when Etanercept is combined with Amcinonide.
Amikacin
Etanercept may decrease the excretion rate of Amikacin which could result in a higher serum level.
Amiloride
Etanercept may decrease the antihypertensive activities of Amiloride.
Aminosalicylic Acid
The risk or severity of adverse effects can be increased when Etanercept is combined with Aminosalicylic Acid.
Amiodarone
Etanercept may decrease the antihypertensive activities of Amiodarone.
Anakinra
The risk or severity of adverse effects can be increased when Etanercept is combined with Anakinra.
Ancrod
Etanercept may increase the anticoagulant activities of Ancrod.
Androstenedione
The risk or severity of adverse effects can be increased when Etanercept is combined with Androstenedione.
Anhydrous Tacrolimus
Tacrolimus may increase the immunosuppressive activities of Etanercept.
Anthrax immune globulin, human
The risk or severity of adverse effects can be increased when Etanercept is combined with Anthrax immune globulin human.
Antipyrine
The risk or severity of adverse effects can be increased when Etanercept is combined with Antipyrine.
Antithrombin III
Etanercept may increase the anticoagulant activities of Antithrombin III human.
Antithrombin III, Human
Etanercept may increase the anticoagulant activities of Antithrombin III human.
Apazone
The risk or severity of adverse effects can be increased when Azapropazone is combined with Etanercept.
Apixaban
Etanercept may increase the anticoagulant activities of Apixaban.
Apremilast
The risk or severity of adverse effects can be increased when Apremilast is combined with Etanercept.
Arbekacin
Etanercept may decrease the excretion rate of Arbekacin which could result in a higher serum level.
Ardeparin
Etanercept may increase the anticoagulant activities of Ardeparin.
Argatroban
Etanercept may increase the anticoagulant activities of Argatroban.
Argatroban Anhydrous
Etanercept may increase the anticoagulant activities of Argatroban.
Asenapine
Etanercept may decrease the antihypertensive activities of Asenapine.
Asian ginseng extract
The risk or severity of adverse effects can be increased when Etanercept is combined with Ginseng.
Atenolol
Etanercept may decrease the antihypertensive activities of Atenolol.
Azelastine
The risk or severity of adverse effects can be increased when Azelastine is combined with Etanercept.
azficel-T
The risk or severity of adverse effects can be increased when Etanercept is combined with Azficel-T.
Azilsartan
The risk or severity of adverse effects can be increased when Azilsartan medoxomil is combined with Etanercept.
Azilsartan kamedoxomil
The risk or severity of adverse effects can be increased when Azilsartan medoxomil is combined with Etanercept.
Azilsartan Medoxomil
The risk or severity of adverse effects can be increased when Azilsartan medoxomil is combined with Etanercept.
Azosemide
The therapeutic efficacy of Azosemide can be decreased when used in combination with Etanercept.
Balsalazide
The risk or severity of adverse effects can be increased when Etanercept is combined with Balsalazide.
Bazedoxifene
Etanercept may increase the thrombogenic activities of Bazedoxifene.
BCG Vaccine
The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Etanercept.
BCG, Live, Connaught Strain
The risk or severity of adverse effects can be increased when Etanercept is combined with Bacillus calmette-guerin substrain connaught live antigen.
BCG, Live, Tice Strain
The risk or severity of adverse effects can be increased when Etanercept is combined with Bacillus calmette-guerin substrain tice live antigen.
Becaplermin
Etanercept may increase the anticoagulant activities of Becaplermin.
Beclomethasone Dipropionate
The risk or severity of adverse effects can be increased when Etanercept is combined with Beclomethasone dipropionate.
Belimumab
The risk or severity of adverse effects can be increased when Etanercept is combined with Belimumab.
Benazepril
The risk or severity of adverse effects can be increased when Etanercept is combined with Benazepril.
Bendroflumethiazide
The therapeutic efficacy of Bendroflumethiazide can be decreased when used in combination with Etanercept.
Benzthiazide
The therapeutic efficacy of Benzthiazide can be decreased when used in combination with Etanercept.
Benzydamine
The risk or severity of adverse effects can be increased when Benzydamine is combined with Etanercept.
Betamethasone
The risk or severity of adverse effects can be increased when Etanercept is combined with Betamethasone.
Betaxolol
Etanercept may decrease the antihypertensive activities of Betaxolol.
Betrixaban
The risk or severity of bleeding can be increased when Betrixaban is combined with Etanercept.
Bimatoprost
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Etanercept.
Bisoprolol
Etanercept may decrease the antihypertensive activities of Bisoprolol.
Bivalirudin
Etanercept may increase the anticoagulant activities of Bivalirudin.
Bopindolol
Etanercept may decrease the antihypertensive activities of Bopindolol.
Bromfenac
The risk or severity of adverse effects can be increased when Bromfenac is combined with Etanercept.
Budesonide
The risk or severity of adverse effects can be increased when Etanercept is combined with Budesonide.
Bufexamac
The risk or severity of adverse effects can be increased when Etanercept is combined with Bufexamac.
Bumetanide
The therapeutic efficacy of Bumetanide can be decreased when used in combination with Etanercept.
Bupranolol
Etanercept may decrease the antihypertensive activities of Bupranolol.
Canakinumab
The risk or severity of infection and neutropenia can be increased when Etanercept is combined with Canakinumab.
Candesartan
The risk or severity of adverse effects can be increased when Candesartan is combined with Etanercept.
Candesartan Cilexetil
The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with Etanercept.
Capsaicin
The risk or severity of adverse effects can be increased when Etanercept is combined with Capsaicin.
Captopril
The risk or severity of adverse effects can be increased when Etanercept is combined with Captopril.
Carboprost
The therapeutic efficacy of Carboprost Tromethamine can be decreased when used in combination with Etanercept.
Carboprost Tromethamine
The therapeutic efficacy of Carboprost Tromethamine can be decreased when used in combination with Etanercept.
Carprofen
The risk or severity of adverse effects can be increased when Etanercept is combined with Carprofen.
Carteolol
Etanercept may decrease the antihypertensive activities of Carteolol.
Carvedilol
Etanercept may decrease the antihypertensive activities of Carvedilol.
Celecoxib
The risk or severity of adverse effects can be increased when Etanercept is combined with Celecoxib.
Celiprolol
Etanercept may decrease the antihypertensive activities of Celiprolol.
Certolizumab Pegol
The risk or severity of infection can be increased when Etanercept is combined with Certolizumab pegol.
Certoparin
Etanercept may increase the anticoagulant activities of Certoparin.
Chloroquine
The risk or severity of adverse effects can be increased when Chloroquine is combined with Etanercept.
Chlorothiazide
The therapeutic efficacy of Chlorothiazide can be decreased when used in combination with Etanercept.
Chlorotrianisene
Etanercept may increase the thrombogenic activities of Chlorotrianisene.
Chlorphenesin
The risk or severity of adverse effects can be increased when Etanercept is combined with Chlorphenesin.
Chlorthalidone
The therapeutic efficacy of Chlorthalidone can be decreased when used in combination with Etanercept.
Cholestyramine Resin
Cholestyramine can cause a decrease in the absorption of Etanercept resulting in a reduced serum concentration and potentially a decrease in efficacy.
Choline Magnesium Trisalicyclate
The risk or severity of adverse effects can be increased when Etanercept is combined with Choline magnesium trisalicylate.
Ciclesonide
The risk or severity of adverse effects can be increased when Etanercept is combined with Ciclesonide.
Cilazapril
The risk or severity of adverse effects can be increased when Etanercept is combined with Cilazapril.
Cinoxacin
Etanercept may increase the neuroexcitatory activities of Cinoxacin.
Ciprofloxacin
Etanercept may increase the neuroexcitatory activities of Ciprofloxacin.
Cisplatin
The risk or severity of adverse effects can be increased when Etanercept is combined with Cisplatin.
Citalopram
Citalopram may increase the antiplatelet activities of Etanercept.
Citric Acid
Etanercept may increase the anticoagulant activities of Citric Acid.
Citric Acid, Anhydrous
Etanercept may increase the anticoagulant activities of Citric Acid.
Clobetasol
The risk or severity of adverse effects can be increased when Etanercept is combined with Clobetasol.
Clobetasol Propionate
The risk or severity of adverse effects can be increased when Etanercept is combined with Clobetasol propionate.
Clobetasone
The risk or severity of adverse effects can be increased when Etanercept is combined with Clobetasone.
Clocortolone
The risk or severity of adverse effects can be increased when Etanercept is combined with Clocortolone.
Clodronic Acid
The risk or severity of adverse effects can be increased when Etanercept is combined with Clodronic Acid.
Clonixin
The risk or severity of adverse effects can be increased when Clonixin is combined with Etanercept.
Colesevelam
Colesevelam can cause a decrease in the absorption of Etanercept resulting in a reduced serum concentration and potentially a decrease in efficacy.
Colestipol
Colestipol can cause a decrease in the absorption of Etanercept resulting in a reduced serum concentration and potentially a decrease in efficacy.
Cortisone Acetate
The risk or severity of adverse effects can be increased when Etanercept is combined with Cortisone acetate.
Curcumin
The risk or severity of adverse effects can be increased when Curcumin is combined with Etanercept.
Cyclopenthiazide
The therapeutic efficacy of Cyclopenthiazide can be decreased when used in combination with Etanercept.
Cyclophosphamide
The risk or severity of adverse effects can be increased when Etanercept is combined with Cyclophosphamide.
Cyclophosphamide Anhydrous
The risk or severity of adverse effects can be increased when Etanercept is combined with Cyclophosphamide.
Cyclosporine
Etanercept may increase the nephrotoxic activities of Cyclosporine.
Dabigatran Etexilate
Etanercept may increase the anticoagulant activities of Dabigatran etexilate.
Dalteparin
Etanercept may increase the anticoagulant activities of Dalteparin.
Danaparoid
Etanercept may increase the anticoagulant activities of Danaparoid.
Deferasirox
The risk or severity of adverse effects can be increased when Etanercept is combined with Deferasirox.
Deflazacort
The risk or severity of adverse effects can be increased when Etanercept is combined with Deflazacort.
Denosumab
The risk or severity of adverse effects can be increased when Denosumab is combined with Etanercept.
Desipramine
Etanercept may decrease the antihypertensive activities of Desipramine.
Desirudin
Etanercept may increase the anticoagulant activities of Desirudin.
Desmopressin
The risk or severity of adverse effects can be increased when Etanercept is combined with Desmopressin.
Desonide
The risk or severity of adverse effects can be increased when Etanercept is combined with Desonide.
Desoximetasone
The risk or severity of adverse effects can be increased when Etanercept is combined with Desoximetasone.
Desoxycorticosterone acetate
The risk or severity of adverse effects can be increased when Etanercept is combined with Desoxycorticosterone acetate.
Desoxycorticosterone Pivalate
The risk or severity of adverse effects can be increased when Etanercept is combined with Desoxycorticosterone Pivalate.
Desvenlafaxine
Desvenlafaxine may increase the antiplatelet activities of Etanercept.
Dexamethasone
The risk or severity of adverse effects can be increased when Etanercept is combined with Dexamethasone.
Dexketoprofen
The risk or severity of adverse effects can be increased when Dexketoprofen is combined with Etanercept.
Dextran
Etanercept may increase the anticoagulant activities of Dextran.
Diclofenac
The risk or severity of adverse effects can be increased when Diclofenac is combined with Etanercept.
Dicumarol
Etanercept may increase the anticoagulant activities of Dicoumarol.
Dienestrol
Etanercept may increase the thrombogenic activities of Dienestrol.
Diethylstilbestrol
Etanercept may increase the thrombogenic activities of Diethylstilbestrol.
Diflorasone
The risk or severity of adverse effects can be increased when Etanercept is combined with Diflorasone.
Diflucortolone
The risk or severity of adverse effects can be increased when Etanercept is combined with Difluocortolone.
Diflunisal
The risk or severity of adverse effects can be increased when Etanercept is combined with Diflunisal.
Difluprednate
The risk or severity of adverse effects can be increased when Etanercept is combined with Difluprednate.
Digoxin
The serum concentration of Digoxin can be increased when it is combined with Etanercept.
Dihydrostreptomycin
Etanercept may decrease the excretion rate of Dihydrostreptomycin which could result in a higher serum level.
Dinoprost
The therapeutic efficacy of Dinoprost can be decreased when used in combination with Etanercept.
Dinoprost Tromethamine
The therapeutic efficacy of Dinoprost Tromethamine can be decreased when used in combination with Etanercept.
Dinoprostone
The therapeutic efficacy of Dinoprostone can be decreased when used in combination with Etanercept.
Dipyrone
The risk or severity of adverse effects can be increased when Metamizole is combined with Etanercept.
Drospirenone
Etanercept may increase the hyperkalemic activities of Drospirenone.
Droxicam
The risk or severity of adverse effects can be increased when Etanercept is combined with Droxicam.
Duloxetine
Duloxetine may increase the antiplatelet activities of Etanercept.
Edetic Acid
Etanercept may increase the anticoagulant activities of Edetic Acid.
Edoxaban
Etanercept may increase the anticoagulant activities of Edoxaban.
Eicosapentaenoic Acid
The risk or severity of adverse effects can be increased when Etanercept is combined with Icosapent.
Enalapril
The risk or severity of adverse effects can be increased when Etanercept is combined with Enalapril.
Enalaprilat
The risk or severity of adverse effects can be increased when Etanercept is combined with Enalaprilat.
Enalaprilat Anhydrous
The risk or severity of adverse effects can be increased when Etanercept is combined with Enalaprilat.
Enoxacin
Etanercept may increase the neuroexcitatory activities of Enoxacin.
Enoxaparin
Etanercept may increase the anticoagulant activities of Enoxaparin.
Enoxaparin sodium
Etanercept may increase the anticoagulant activities of Enoxaparin.
Eplerenone
Etanercept may decrease the antihypertensive activities of Eplerenone.
Epoprostenol
The therapeutic efficacy of Epoprostenol can be decreased when used in combination with Etanercept.
Eprosartan
The risk or severity of adverse effects can be increased when Eprosartan is combined with Etanercept.
Equol, (-)-
Etanercept may increase the thrombogenic activities of Equol.
Escitalopram
Escitalopram may increase the antiplatelet activities of Etanercept.
Esmolol
Etanercept may decrease the antihypertensive activities of Esmolol.
Estradiol
Etanercept may increase the thrombogenic activities of Estradiol.
Estradiol acetate
Etanercept may increase the thrombogenic activities of Estradiol acetate.
Estradiol Cypionate
Etanercept may increase the thrombogenic activities of Estradiol cypionate.
Estradiol Valerate
Etanercept may increase the thrombogenic activities of Estradiol valerate.
Estriol
Etanercept may increase the thrombogenic activities of Estriol.
Estrogens, Conjugated (USP)
Etanercept may increase the thrombogenic activities of Conjugated estrogens.
Estrogens, Esterified (USP)
Etanercept may increase the thrombogenic activities of Estrogens, esterified.
Estrone
The risk or severity of adverse effects can be increased when Etanercept is combined with Estrone.
Ethacrynate
The therapeutic efficacy of Etacrynic acid can be decreased when used in combination with Etanercept.
Ethacrynic Acid
The therapeutic efficacy of Etacrynic acid can be decreased when used in combination with Etanercept.
Ethinyl Estradiol
Etanercept may increase the thrombogenic activities of Ethinyl Estradiol.
Ethylenediaminetetraacetate
Etanercept may increase the anticoagulant activities of Edetic Acid.
Etidronate
The risk or severity of adverse effects can be increased when Etanercept is combined with Etidronic acid.
Etidronic Acid
The risk or severity of adverse effects can be increased when Etanercept is combined with Etidronic acid.
Etodolac
The risk or severity of adverse effects can be increased when Etanercept is combined with Etodolac.
Etofenamate
The risk or severity of adverse effects can be increased when Etofenamate is combined with Etanercept.
Etoricoxib
The risk or severity of adverse effects can be increased when Etanercept is combined with Etoricoxib.
Evening primrose oil
The risk or severity of adverse effects can be increased when Evening primrose oil is combined with Etanercept.
Felbinac
The risk or severity of adverse effects can be increased when Felbinac is combined with Etanercept.
Fenbufen
The risk or severity of adverse effects can be increased when Fenbufen is combined with Etanercept.
Fenoprofen
The risk or severity of adverse effects can be increased when Etanercept is combined with Fenoprofen.
Ferulic Acid
The risk or severity of adverse effects can be increased when Ferulic acid is combined with Etanercept.
Fingolimod
Etanercept may increase the immunosuppressive activities of Fingolimod.
Fish Oils
The risk or severity of adverse effects can be increased when Etanercept is combined with Fish oil.
Fleroxacin
Etanercept may increase the neuroexcitatory activities of Fleroxacin.
Floctafenine
The risk or severity of adverse effects can be increased when Floctafenine is combined with Etanercept.
Fludrocortisone
The risk or severity of adverse effects can be increased when Etanercept is combined with Fludrocortisone.
Fluindione
Etanercept may increase the anticoagulant activities of Fluindione.
Flumequine
Etanercept may increase the neuroexcitatory activities of Flumequine.
Flumethasone
The risk or severity of adverse effects can be increased when Etanercept is combined with Flumethasone.
Flunisolide
The risk or severity of adverse effects can be increased when Etanercept is combined with Flunisolide.
Flunisolide Anhydrous (obsolete)
The risk or severity of adverse effects can be increased when Etanercept is combined with Flunisolide.
Fluocinolone Acetonide
The risk or severity of adverse effects can be increased when Etanercept is combined with Fluocinolone Acetonide.
Fluocinonide
The risk or severity of adverse effects can be increased when Etanercept is combined with Fluocinonide.
Fluocortolone
The risk or severity of adverse effects can be increased when Etanercept is combined with Fluocortolone.
Fluorometholone
The risk or severity of adverse effects can be increased when Etanercept is combined with Fluorometholone.
Fluoxetine
Fluoxetine may increase the antiplatelet activities of Etanercept.
FLUPREDNIDENE
The risk or severity of adverse effects can be increased when Etanercept is combined with Fluprednidene.
Fluprednisolone
The risk or severity of adverse effects can be increased when Etanercept is combined with Fluprednisolone.
Flurandrenolide
The risk or severity of adverse effects can be increased when Etanercept is combined with Flurandrenolide.
Flurbiprofen
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Etanercept.
Fluticasone
The risk or severity of adverse effects can be increased when Etanercept is combined with Fluticasone.
Fluticasone Furoate
The risk or severity of adverse effects can be increased when Etanercept is combined with Fluticasone furoate.
Fluticasone propionate
The risk or severity of adverse effects can be increased when Etanercept is combined with Fluticasone propionate.
Fluvoxamine
Fluvoxamine may increase the antiplatelet activities of Etanercept.
Folate
The therapeutic efficacy of Folic Acid can be decreased when used in combination with Etanercept.
Folic Acid
The therapeutic efficacy of Folic Acid can be decreased when used in combination with Etanercept.
Fondaparinux sodium
Etanercept may increase the anticoagulant activities of Fondaparinux sodium.
Formestane
The risk or severity of adverse effects can be increased when Etanercept is combined with Formestane.
Fosinopril
The risk or severity of adverse effects can be increased when Etanercept is combined with Fosinopril.
Framycetin
Etanercept may decrease the excretion rate of Framycetin which could result in a higher serum level.
Furosemide
The therapeutic efficacy of Furosemide can be decreased when used in combination with Etanercept.
Gatifloxacin
Etanercept may increase the neuroexcitatory activities of Gatifloxacin.
Gatifloxacin Anhydrous
Etanercept may increase the neuroexcitatory activities of Gatifloxacin.
Gemeprost
The therapeutic efficacy of Gemeprost can be decreased when used in combination with Etanercept.
Gemifloxacin
Etanercept may increase the neuroexcitatory activities of Gemifloxacin.
Gemifloxacin Mesylate
Etanercept may increase the neuroexcitatory activities of Gemifloxacin.
Genistein
Etanercept may increase the thrombogenic activities of Genistein.
Gentamicin
Etanercept may decrease the excretion rate of Gentamicin which could result in a higher serum level.
Ginseng Preparation
The risk or severity of adverse effects can be increased when Etanercept is combined with Ginseng.
Golimumab
The risk or severity of adverse effects can be increased when Etanercept is combined with Golimumab.
Grepafloxacin
Etanercept may increase the neuroexcitatory activities of Grepafloxacin.
Halcinonide
The risk or severity of adverse effects can be increased when Etanercept is combined with Halcinonide.
Halobetasol
The risk or severity of adverse effects can be increased when Etanercept is combined with Ulobetasol.
Haloperidol
The risk or severity of adverse effects can be increased when Etanercept is combined with Haloperidol.
Heparin
Etanercept may increase the anticoagulant activities of Heparin.
Hepatitis A Vaccine, Inactivated
The risk or severity of adverse effects can be increased when Etanercept is combined with Hepatitis A Vaccine.
Hepatitis B Surface Antigen Vaccine
The risk or severity of adverse effects can be increased when Etanercept is combined with Hepatitis B Vaccine (Recombinant).
Hydralazine
Etanercept may decrease the antihypertensive activities of Hydralazine.
Hydrochlorothiazide
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Etanercept.
Hydrocortisone
The risk or severity of adverse effects can be increased when Etanercept is combined with Hydrocortisone.
Hydroflumethiazide
The therapeutic efficacy of Hydroflumethiazide can be decreased when used in combination with Etanercept.
Ibandronate
The risk or severity of adverse effects can be increased when Etanercept is combined with Ibandronate.
Ibandronic Acid
The risk or severity of adverse effects can be increased when Etanercept is combined with Ibandronate.
Ibuprofen
The risk or severity of adverse effects can be increased when Etanercept is combined with Ibuprofen.
Icatibant
The risk or severity of adverse effects can be increased when Icatibant is combined with Etanercept.
Iloprost
The therapeutic efficacy of Iloprost can be decreased when used in combination with Etanercept.
Imidapril
The risk or severity of adverse effects can be increased when Etanercept is combined with Imidapril.
Indapamide
The therapeutic efficacy of Indapamide can be decreased when used in combination with Etanercept.
Indobufen
The risk or severity of adverse effects can be increased when Indobufen is combined with Etanercept.
Indomethacin
The risk or severity of adverse effects can be increased when Etanercept is combined with Indomethacin.
Infliximab
Etanercept may increase the immunosuppressive activities of Infliximab.
Infliximab-Abda
Etanercept may increase the immunosuppressive activities of Infliximab.
Infliximab-Dyyb
Etanercept may increase the immunosuppressive activities of Infliximab.
Irbesartan
The risk or severity of adverse effects can be increased when Irbesartan is combined with Etanercept.
Kanamycin
Etanercept may decrease the excretion rate of Kanamycin which could result in a higher serum level.
kanamycin A
Etanercept may decrease the excretion rate of Kanamycin which could result in a higher serum level.
Kebuzone
The risk or severity of adverse effects can be increased when Kebuzone is combined with Etanercept.
Ketoprofen
The risk or severity of adverse effects can be increased when Etanercept is combined with Ketoprofen.
Ketorolac
The risk or severity of adverse effects can be increased when Ketorolac is combined with Etanercept.
Korean ginseng preparation
The risk or severity of adverse effects can be increased when Etanercept is combined with Ginseng.
KOREAN GINSENG ROOT
The risk or severity of adverse effects can be increased when Etanercept is combined with Ginseng.
Korean Ginseng Root Extract
The risk or severity of adverse effects can be increased when Etanercept is combined with Ginseng.
Labetalol
Etanercept may decrease the antihypertensive activities of Labetalol.
Latanoprost
The therapeutic efficacy of Latanoprost can be decreased when used in combination with Etanercept.
Latanoprostene Bunod
The therapeutic efficacy of Latanoprostene Bunod can be decreased when used in combination with Etanercept.
Leflunomide
The risk or severity of adverse effects can be increased when Etanercept is combined with Leflunomide.
Lepirudin
Etanercept may increase the anticoagulant activities of Lepirudin.
Levobetaxolol
Etanercept may decrease the antihypertensive activities of Levobetaxolol.
Levobunolol
Etanercept may decrease the antihypertensive activities of Levobunolol.
Levofloxacin
Etanercept may increase the neuroexcitatory activities of Levofloxacin.
Levofloxacin Anhydrous
Etanercept may increase the neuroexcitatory activities of Levofloxacin.
Levomilnacipran
Levomilnacipran may increase the antiplatelet activities of Etanercept.
Limonene, (+)-
The risk or severity of adverse effects can be increased when (4R)-limonene is combined with Etanercept.
Lisinopril
The risk or severity of adverse effects can be increased when Etanercept is combined with Lisinopril.
Lisinopril Anhydrous
The risk or severity of adverse effects can be increased when Etanercept is combined with Lisinopril.
Lithium
The serum concentration of Lithium can be increased when it is combined with Etanercept.
Lithium Cation
The serum concentration of Lithium can be increased when it is combined with Etanercept.
Lomefloxacin
Etanercept may increase the neuroexcitatory activities of Lomefloxacin.
Lornoxicam
The risk or severity of adverse effects can be increased when Etanercept is combined with Lornoxicam.
Losartan
The risk or severity of adverse effects can be increased when Losartan is combined with Etanercept.
Loteprednol
The risk or severity of adverse effects can be increased when Etanercept is combined with Loteprednol.
Loxoprofen
The risk or severity of adverse effects can be increased when Loxoprofen is combined with Etanercept.
Lubiprostone
The therapeutic efficacy of Lubiprostone can be decreased when used in combination with Etanercept.
Magnesium Salicylate
The risk or severity of adverse effects can be increased when Etanercept is combined with Magnesium salicylate.
Masoprocol
The risk or severity of adverse effects can be increased when Masoprocol is combined with Etanercept.
Meclofenamate
The risk or severity of adverse effects can be increased when Etanercept is combined with Meclofenamic acid.
Meclofenamic Acid
The risk or severity of adverse effects can be increased when Etanercept is combined with Meclofenamic acid.
Medronate
The risk or severity of adverse effects can be increased when Etanercept is combined with Technetium Tc-99m medronate.
Medrysone
The risk or severity of adverse effects can be increased when Etanercept is combined with Medrysone.
Mefenamic Acid
The risk or severity of adverse effects can be increased when Etanercept is combined with Mefenamic acid.
Meloxicam
The risk or severity of adverse effects can be increased when Etanercept is combined with Meloxicam.
Mepindolol
Etanercept may decrease the antihypertensive activities of Mepindolol.
Mesalamine
The risk or severity of adverse effects can be increased when Etanercept is combined with Mesalazine.
Mestranol
Etanercept may increase the thrombogenic activities of Mestranol.
Methotrexate
The serum concentration of Methotrexate can be increased when it is combined with Etanercept.
Methyclothiazide
The therapeutic efficacy of Methyclothiazide can be decreased when used in combination with Etanercept.
Methylprednisolone
The risk or severity of adverse effects can be increased when Etanercept is combined with Methylprednisolone.
Metipranolol
Etanercept may decrease the antihypertensive activities of Metipranolol.
Metolazone
The therapeutic efficacy of Metolazone can be decreased when used in combination with Etanercept.
Metoprolol
Etanercept may decrease the antihypertensive activities of Metoprolol.
Milnacipran
Milnacipran may increase the antiplatelet activities of Etanercept.
Misoprostol
The therapeutic efficacy of Misoprostol can be decreased when used in combination with Etanercept.
Moexipril
The risk or severity of adverse effects can be increased when Etanercept is combined with Moexipril.
Mometasone
The risk or severity of adverse effects can be increased when Etanercept is combined with Mometasone.
Morniflumate
The risk or severity of adverse effects can be increased when Morniflumate is combined with Etanercept.
Moxifloxacin
Etanercept may increase the neuroexcitatory activities of Moxifloxacin.
MYCOPHENOLATE
The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Etanercept.
Mycophenolate Mofetil
The risk or severity of adverse effects can be increased when Mycophenolate mofetil is combined with Etanercept.
Mycophenolic Acid
The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Etanercept.
Nabumetone
The risk or severity of adverse effects can be increased when Etanercept is combined with Nabumetone.
Nadolol
Etanercept may decrease the antihypertensive activities of Nadolol.
Nadroparin
Etanercept may increase the anticoagulant activities of Nadroparin.
Naftifine
The risk or severity of adverse effects can be increased when Naftifine is combined with Etanercept.
Nalidixic Acid
Etanercept may increase the neuroexcitatory activities of Nalidixic Acid.
Naproxen
The risk or severity of adverse effects can be increased when Etanercept is combined with Naproxen.
Natalizumab
The risk or severity of adverse effects can be increased when Etanercept is combined with Natalizumab.
Nebivolol
Etanercept may decrease the antihypertensive activities of Nebivolol.
Nefazodone
Nefazodone may increase the antiplatelet activities of Etanercept.
Neomycin
Etanercept may decrease the excretion rate of Neomycin which could result in a higher serum level.
Nepafenac
The risk or severity of adverse effects can be increased when Nepafenac is combined with Etanercept.
Netilmicin
Etanercept may decrease the excretion rate of Netilmicin which could result in a higher serum level.
Niflumic Acid
The risk or severity of adverse effects can be increased when Etanercept is combined with Niflumic Acid.
Nimesulide
The risk or severity of adverse effects can be increased when Etanercept is combined with Nimesulide.
Norfloxacin
Etanercept may increase the neuroexcitatory activities of Norfloxacin.
Ocrelizumab
Ocrelizumab may increase the immunosuppressive activities of Etanercept.
Oenothera biennis seed extract
The risk or severity of adverse effects can be increased when Evening primrose oil is combined with Etanercept.
Ofloxacin
Etanercept may increase the neuroexcitatory activities of Ofloxacin.
Olmesartan
The risk or severity of adverse effects can be increased when Olmesartan is combined with Etanercept.
Olopatadine
The risk or severity of adverse effects can be increased when Olopatadine is combined with Etanercept.
Olsalazine
The risk or severity of adverse effects can be increased when Olsalazine is combined with Etanercept.
Omacetaxine Mepesuccinate
The risk or severity of bleeding can be increased when Etanercept is combined with Omacetaxine mepesuccinate.
Oxaprozin
The risk or severity of adverse effects can be increased when Etanercept is combined with Oxaprozin.
Oxprenolol
Etanercept may decrease the antihypertensive activities of Oxprenolol.
Oxyphenbutazone
The risk or severity of adverse effects can be increased when Oxyphenbutazone is combined with Etanercept.
Palmidrol
The risk or severity of adverse effects can be increased when Palmidrol is combined with Etanercept.
Pamidronate
The risk or severity of adverse effects can be increased when Etanercept is combined with Pamidronate.
Pamidronic Acid
The risk or severity of adverse effects can be increased when Etanercept is combined with Pamidronate.
Paramethasone
The risk or severity of adverse effects can be increased when Etanercept is combined with Paramethasone.
Parecoxib
The risk or severity of adverse effects can be increased when Etanercept is combined with Parecoxib.
Paromomycin
Etanercept may decrease the excretion rate of Paromomycin which could result in a higher serum level.
Paroxetine
Paroxetine may increase the antiplatelet activities of Etanercept.
Parthenolide
The risk or severity of adverse effects can be increased when Parthenolide is combined with Etanercept.
Pefloxacin
Etanercept may increase the neuroexcitatory activities of Pefloxacin.
Penbutolol
Etanercept may decrease the antihypertensive activities of Penbutolol.
Pentaerythritol Tetranitrate
Etanercept may increase the anticoagulant activities of Pentaerythritol Tetranitrate.
Pentosan Polysulfate
Etanercept may increase the anticoagulant activities of Pentosan Polysulfate.
Perindopril
The risk or severity of adverse effects can be increased when Etanercept is combined with Perindopril.
Phenindione
Etanercept may increase the anticoagulant activities of Phenindione.
Phenprocoumon
Etanercept may increase the anticoagulant activities of Phenprocoumon.
Phenylbutazone
The risk or severity of adverse effects can be increased when Etanercept is combined with Phenylbutazone.
Pimecrolimus
The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Etanercept.
Pindolol
Etanercept may decrease the antihypertensive activities of Pindolol.
Piretanide
The therapeutic efficacy of Piretanide can be decreased when used in combination with Etanercept.
Pirfenidone
The risk or severity of adverse effects can be increased when Pirfenidone is combined with Etanercept.
Piroxicam
The risk or severity of adverse effects can be increased when Etanercept is combined with Piroxicam.
Piroxicam-Beta-Cyclodextrin
The risk or severity of adverse effects can be increased when Etanercept is combined with Piroxicam.
Plazomicin
Etanercept may decrease the excretion rate of Plazomicin which could result in a higher serum level.
Polyestradiol Phosphate
Etanercept may increase the thrombogenic activities of Polyestradiol phosphate.
Polythiazide
The therapeutic efficacy of Polythiazide can be decreased when used in combination with Etanercept.
Pomalidomide
The risk or severity of adverse effects can be increased when Etanercept is combined with Pomalidomide.
Potassium Citrate
Etanercept may increase the anticoagulant activities of Potassium Citrate.
Practolol
Etanercept may decrease the antihypertensive activities of Practolol.
Pralatrexate
The serum concentration of Pralatrexate can be increased when it is combined with Etanercept.
Prasterone
The risk or severity of adverse effects can be increased when Etanercept is combined with Prasterone.
Prednicarbate
The risk or severity of adverse effects can be increased when Etanercept is combined with Prednicarbate.
Prednisolone
The risk or severity of adverse effects can be increased when Etanercept is combined with Prednisolone.
Prednisone
The risk or severity of adverse effects can be increased when Etanercept is combined with Prednisone.
Pregnenolone
The risk or severity of adverse effects can be increased when Etanercept is combined with Pregnenolone.
Probenecid
The serum concentration of Etanercept can be increased when it is combined with Probenecid.
Promestriene
Etanercept may increase the thrombogenic activities of Promestriene.
Propafenone
Etanercept may decrease the antihypertensive activities of Propafenone.
Propranolol
Etanercept may decrease the antihypertensive activities of Propranolol.
protein C, human
Etanercept may increase the anticoagulant activities of Protein C.
protein S, human
Etanercept may increase the anticoagulant activities of Protein S human.
Protocatechualdehyde
Etanercept may increase the anticoagulant activities of Protocatechualdehyde.
Quinapril
The risk or severity of adverse effects can be increased when Etanercept is combined with Quinapril.
Quinestrol
Etanercept may increase the thrombogenic activities of Quinestrol.
Quinethazone
The therapeutic efficacy of Quinethazone can be decreased when used in combination with Etanercept.
Rabies Immune Globulin, Human
The risk or severity of adverse effects can be increased when Etanercept is combined with Human rabies virus immune globulin.
Rabies Virus Vaccine Flury-Lep Strain
The risk or severity of adverse effects can be increased when Etanercept is combined with Rabies virus inactivated antigen, A.
Ramipril
The risk or severity of adverse effects can be increased when Etanercept is combined with Ramipril.
Rescinnamine
The risk or severity of adverse effects can be increased when Etanercept is combined with Rescinnamine.
Resveratrol
The risk or severity of adverse effects can be increased when Etanercept is combined with Resveratrol.
Reviparin
Etanercept may increase the anticoagulant activities of Reviparin.
Reviparin sodium
Etanercept may increase the anticoagulant activities of Reviparin.
Rilonacept
The risk or severity of adverse effects can be increased when Etanercept is combined with Rilonacept.
Rimexolone
The risk or severity of adverse effects can be increased when Etanercept is combined with Rimexolone.
Risedronate
The risk or severity of adverse effects can be increased when Etanercept is combined with Risedronate.
Risedronic Acid
The risk or severity of adverse effects can be increased when Etanercept is combined with Risedronate.
Rituximab
The risk or severity of adverse effects can be increased when Etanercept is combined with Rituximab.
Rivaroxaban
Etanercept may increase the anticoagulant activities of Rivaroxaban.
Rofecoxib
The risk or severity of adverse effects can be increased when Etanercept is combined with Rofecoxib.
Roflumilast
Roflumilast may increase the immunosuppressive activities of Etanercept.
Rosoxacin
Etanercept may increase the neuroexcitatory activities of Rosoxacin.
ROTAVIRUS VACCINE, LIVE
The risk or severity of adverse effects can be increased when Etanercept is combined with Rotavirus Vaccine.
Rubella Virus Vaccine Live (wistar Ra 27-3 Strain)
The risk or severity of adverse effects can be increased when Etanercept is combined with Rubella virus vaccine.
Sacubitril
The risk or severity of adverse effects can be increased when Sacubitril is combined with Etanercept.
Salicylamide
The risk or severity of adverse effects can be increased when Salicylamide is combined with Etanercept.
Salicylic Acid
The risk or severity of adverse effects can be increased when Etanercept is combined with Salicylic acid.
Salmonella enterica subsp. enterica serovar typhi
The risk or severity of adverse effects can be increased when Etanercept is combined with Salmonella typhi ty21a live antigen.
Salsalate
The risk or severity of adverse effects can be increased when Etanercept is combined with Salsalate.
Saralasin
The risk or severity of adverse effects can be increased when Saralasin is combined with Etanercept.
Sarilumab
Sarilumab may increase the immunosuppressive activities of Etanercept.
Serratiopeptidase
The risk or severity of adverse effects can be increased when Serrapeptase is combined with Etanercept.
Sertraline
Sertraline may increase the antiplatelet activities of Etanercept.
sipuleucel-T
The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Etanercept.
Sisomicin
Etanercept may decrease the excretion rate of Sisomicin which could result in a higher serum level.
Sodium Citrate
Etanercept may increase the anticoagulant activities of Sodium Citrate.
Sodium Phosphate
Sodium phosphate may increase the nephrotoxic activities of Etanercept.
Sodium Phosphate, Monobasic
Sodium phosphate may increase the nephrotoxic activities of Etanercept.
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS
Sodium phosphate may increase the nephrotoxic activities of Etanercept.
Sotalol
Etanercept may decrease the antihypertensive activities of Sotalol.
Sparfloxacin
Etanercept may increase the neuroexcitatory activities of Sparfloxacin.
Spirapril
The risk or severity of adverse effects can be increased when Etanercept is combined with Spirapril.
Spironolactone
Etanercept may decrease the antihypertensive activities of Spironolactone.
Streptomycin
Etanercept may decrease the excretion rate of Streptomycin which could result in a higher serum level.
Sulfasalazine
The risk or severity of adverse effects can be increased when Etanercept is combined with Sulfasalazine.
Sulindac
The risk or severity of adverse effects can be increased when Etanercept is combined with Sulindac.
Suprofen
The risk or severity of adverse effects can be increased when Etanercept is combined with Suprofen.
synthetic conjugated estrogens, A
Etanercept may increase the thrombogenic activities of Synthetic Conjugated Estrogens, A.
synthetic conjugated estrogens, B
Etanercept may increase the thrombogenic activities of Synthetic Conjugated Estrogens, B.
Tacrolimus
Tacrolimus may increase the immunosuppressive activities of Etanercept.
Tafluprost
The therapeutic efficacy of Tafluprost can be decreased when used in combination with Etanercept.
Talinolol
Etanercept may decrease the antihypertensive activities of Talinolol.
Talniflumate
The risk or severity of adverse effects can be increased when Talniflumate is combined with Etanercept.
Technetium Tc 99m Medronate
The risk or severity of adverse effects can be increased when Etanercept is combined with Technetium Tc-99m medronate.
Telmisartan
The risk or severity of adverse effects can be increased when Telmisartan is combined with Etanercept.
Temafloxacin
Etanercept may increase the neuroexcitatory activities of Temafloxacin.
Tenofovir Disoproxil
The risk or severity of adverse effects can be increased when Etanercept is combined with Tenofovir disoproxil.
Tenoxicam
The risk or severity of adverse effects can be increased when Etanercept is combined with Tenoxicam.
Terbutaline
Etanercept may decrease the antihypertensive activities of Terbutaline.
Terbutaline Sulfate
Etanercept may decrease the antihypertensive activities of Terbutaline.
Teriflunomide
The risk or severity of adverse effects can be increased when Teriflunomide is combined with Etanercept.
Tertatolol
Etanercept may decrease the antihypertensive activities of Tertatolol.
Tetanus Toxoid Vaccine, Inactivated
The risk or severity of adverse effects can be increased when Etanercept is combined with Clostridium tetani toxoid antigen (formaldehyde inactivated).
Tiaprofenic Acid
The risk or severity of adverse effects can be increased when Etanercept is combined with Tiaprofenic acid.
Tibolone
Etanercept may increase the thrombogenic activities of Tibolone.
Tiludronate
The risk or severity of adverse effects can be increased when Etanercept is combined with Tiludronic acid.
Tiludronic Acid
The risk or severity of adverse effects can be increased when Etanercept is combined with Tiludronic acid.
Timolol
Etanercept may decrease the antihypertensive activities of Timolol.
Timolol Anhydrous
Etanercept may decrease the antihypertensive activities of Timolol.
Tixocortol
The risk or severity of adverse effects can be increased when Etanercept is combined with Tixocortol.
Tobramycin
Etanercept may decrease the excretion rate of Tobramycin which could result in a higher serum level.
Tocilizumab
Tocilizumab may increase the immunosuppressive activities of Etanercept.
Tofacitinib
The risk or severity of adverse effects can be increased when Etanercept is combined with Tofacitinib.
Tolfenamic Acid
The risk or severity of adverse effects can be increased when Tolfenamic Acid is combined with Etanercept.
Tolmetin
The risk or severity of adverse effects can be increased when Etanercept is combined with Tolmetin.
Torsemide
The therapeutic efficacy of Torasemide can be decreased when used in combination with Etanercept.
Trandolapril
The risk or severity of adverse effects can be increased when Etanercept is combined with Trandolapril.
Tranilast
The risk or severity of adverse effects can be increased when Tranilast is combined with Etanercept.
Trastuzumab
Trastuzumab may increase the neutropenic activities of Etanercept.
Travoprost
The therapeutic efficacy of Travoprost can be decreased when used in combination with Etanercept.
Treprostinil
The risk or severity of adverse effects can be increased when Treprostinil is combined with Etanercept.
Triamcinolone
The risk or severity of adverse effects can be increased when Etanercept is combined with Triamcinolone.
Triamterene
Etanercept may decrease the antihypertensive activities of Triamterene.
Tribenoside
The risk or severity of adverse effects can be increased when Tribenoside is combined with Etanercept.
Trichlormethiazide
The therapeutic efficacy of Trichlormethiazide can be decreased when used in combination with Etanercept.
Trisodium Citrate Anhydrous
Etanercept may increase the anticoagulant activities of Sodium Citrate.
Trolamine Salicylate
The risk or severity of adverse effects can be increased when Etanercept is combined with Trolamine salicylate.
Trovafloxacin
Etanercept may increase the neuroexcitatory activities of Trovafloxacin.
Troxerutin
Etanercept may increase the anticoagulant activities of Troxerutin.
Typhoid Vaccine Live Ty21a
The risk or severity of adverse effects can be increased when Etanercept is combined with Salmonella typhi ty21a live antigen.
Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain
The risk or severity of adverse effects can be increased when Etanercept is combined with Salmonella typhi ty2 vi polysaccharide antigen.
UNOPROSTONE
The therapeutic efficacy of Unoprostone can be decreased when used in combination with Etanercept.
Valdecoxib
The risk or severity of adverse effects can be increased when Etanercept is combined with Valdecoxib.
Valsartan
The risk or severity of adverse effects can be increased when Valsartan is combined with Etanercept.
Vancomycin
The serum concentration of Vancomycin can be increased when it is combined with Etanercept.
Varicella Virus Vaccine Live (Oka-Merck) strain
The risk or severity of adverse effects can be increased when Etanercept is combined with Varicella Zoster Vaccine (Live/Attenuated).
Vedolizumab
The risk or severity of infection can be increased when Etanercept is combined with Vedolizumab.
Venlafaxine
Venlafaxine may increase the antiplatelet activities of Etanercept.
Warfarin
Etanercept may increase the anticoagulant activities of Warfarin.
Yellow Fever Vaccine
The risk or severity of adverse effects can be increased when Etanercept is combined with Yellow Fever Vaccine.
Yellow-Fever Virus Vaccine, 17D-204 strain
The risk or severity of adverse effects can be increased when Etanercept is combined with Yellow Fever Vaccine.
Zileuton
The risk or severity of adverse effects can be increased when Zileuton is combined with Etanercept.
Zofenopril
The risk or severity of adverse effects can be increased when Etanercept is combined with Zofenopril.
Zoledronic Acid
The risk or severity of adverse effects can be increased when Etanercept is combined with Zoledronic acid.
Zoledronic Acid Anhydrous
The risk or severity of adverse effects can be increased when Etanercept is combined with Zoledronic acid.
Zomepirac
The risk or severity of adverse effects can be increased when Zomepirac is combined with Etanercept.
